EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Conserved B-Cell Epitope Candidates Associated with Neutralizing Activity of Bovine Coronavirus Spike Protein

Yunxin Ren iD, Hua Yue, Cheng Tang, Xi Chen

Animals · 20.08.2026 · 16 (16) · 2598

DOI: 10.3390/ani16162598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animals, online erschienen am 20.08.2026. Verfasst von Yunxin Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Medicine of Sichuan Education Department, Southwest Minzu University, Chengdu 610041, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China during the 14th Five-Year Plan, Southwest Minzu University Double World-Class Project, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bovine coronavirus (BCoV) is a major cause of respiratory and enteric diseases in cattle, resulting in substantial economic losses to the global cattle industry. Next-generation epitope-focused vaccines require conserved neutralizing determinants to achieve broad protective efficacy across circulating variants. Here, we applied a reverse-vaccinology and immunoinformatics-guided strategy to identify conserved linear B-cell epitope candidates on the BCoV spike protein. Using ABCPred (16 aa; threshold score 0.51), 139 putative linear B-cell epitopes were predicted, and 10 candidates (B1–B10) were selected based on antigenicity, allergenicity/toxicity filters, and Shannon-entropy-based conservation (≥95%). Each candidate was displayed on Helicobacter pylori ferritin and TEM confirmed the formation of self-assembled nanocages. BALB/c mice (n = 6 per group) were subcutaneously immunized with 50 μg of each epitope–ferritin fusion protein emulsified 1:1 with Montanide ISA 201 in a prime–boost regimen (at a 14-day interval), and sera were collected 14 days after the booster immunization. All 10 constructs induced BCoV-specific binding IgG (endpoint titers ranging from 1:2667 to 1:11,733), but only B1, B2, B4, B6, B7, and B8 elicited detectable in vitro neutralizing activity against both representative strains, whereas B3, B5, B9, and B10 remained below the detection limit ( 0.05). Overall, these findings identify six conserved B-cell epitope candidates capable of eliciting neutralizing antibody responses against both representative enteric and respiratory field strains, providing experimental evidence to support epitope-focused BCoV vaccine design.

Schlagwörter

Stichwörter der Autor:innen

B-cell epitope candidatesbovine coronavirusferritin nanoparticleneutralizing antibodyspike protein

Autor:innen und Institutionen

  • Key Laboratory of Animal Medicine of Sichuan Education Department, Southwest Minzu University, Chengdu 610041, China.

ORCID-Profile: Yunxin Ren

Förderung

  • National Key Research and Development Program of China during the 14th Five-Year Plan
  • Southwest Minzu University Double World-Class Project
  • National Key Research and Development Program of China
  • Southwest Minzu University

Zitieren

APA

Ren, Y., Yue, H., Tang, C., & Chen, X. (2026). Identification of Conserved B-Cell Epitope Candidates Associated with Neutralizing Activity of Bovine Coronavirus Spike Protein. Animals, 16(16), 2598. https://doi.org/10.3390/ani16162598

Vancouver

Ren Y, Yue H, Tang C, Chen X. Identification of Conserved B-Cell Epitope Candidates Associated with Neutralizing Activity of Bovine Coronavirus Spike Protein. Animals. 2026;16(16):2598. doi:10.3390/ani16162598

BibTeX
@article{Ren2026,
  author = {Ren, Yunxin and Yue, Hua and Tang, Cheng and Chen, Xi},
  title = {Identification of Conserved B-Cell Epitope Candidates Associated with Neutralizing Activity of Bovine Coronavirus Spike Protein},
  journal = {Animals},
  year = {2026},
  volume = {16},
  number = {16},
  pages = {2598},
  doi = {10.3390/ani16162598}
}
Kostenlos starten →